Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Biomarkers in Cancer [[electronic resource] /] / edited by Victor R. Preedy, Vinood B. Patel
| Biomarkers in Cancer [[electronic resource] /] / edited by Victor R. Preedy, Vinood B. Patel |
| Pubbl/distr/stampa | Dordrecht : , : Springer Netherlands : , : Imprint : Springer, , 2020 |
| Descrizione fisica | 1 online resource (800 p. 50 illus.) |
| Disciplina | 614.5999 |
| Collana | Biomarkers in Disease: Methods, Discoveries and Applications |
| Soggetto topico |
Cancer research
Oncology Pharmacology Cancer Research Oncology Pharmacology/Toxicology |
| ISBN | 94-007-7744-2 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910349266803321 |
| Dordrecht : , : Springer Netherlands : , : Imprint : Springer, , 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Biomarkers in Cardiovascular Disease [[electronic resource] /] / edited by Vinood B. Patel, Victor R. Preedy
| Biomarkers in Cardiovascular Disease [[electronic resource] /] / edited by Vinood B. Patel, Victor R. Preedy |
| Pubbl/distr/stampa | Dordrecht : , : Springer Netherlands : , : Imprint : Springer, , 2020 |
| Descrizione fisica | 1 online resource (Approx. 800 p. 50 illus.) |
| Disciplina | 614.5999 |
| Collana | Biomarkers in Disease: Methods, Discoveries and Applications |
| Soggetto topico |
Cancer research
Oncology Pharmacology Cancer Research Oncology Pharmacology/Toxicology |
| ISBN | 94-007-7741-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Cardiolog -- Addictions -- Immunology -- Birth Defects -- Genetics. |
| Record Nr. | UNINA-9910349266203321 |
| Dordrecht : , : Springer Netherlands : , : Imprint : Springer, , 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Biomarkers in Kidney Disease [[electronic resource] /] / edited by Vinood B. Patel, Victor R. Preedy
| Biomarkers in Kidney Disease [[electronic resource] /] / edited by Vinood B. Patel, Victor R. Preedy |
| Pubbl/distr/stampa | Dordrecht : , : Springer Netherlands : , : Imprint : Springer, , 2020 |
| Descrizione fisica | 1 online resource (Approx. 800 p. 50 illus.) |
| Disciplina | 614.5999 |
| Collana | Biomarkers in Disease: Methods, Discoveries and Applications |
| Soggetto topico |
Cancer research
Oncology Pharmacology Cancer Research Oncology Pharmacology/Toxicology |
| ISBN | 94-007-7743-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Endocrinology -- Addictions -- Immunology -- Genetics. |
| Record Nr. | UNINA-9910349266503321 |
| Dordrecht : , : Springer Netherlands : , : Imprint : Springer, , 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Biomarkers in Liver Disease [[electronic resource] /] / edited by Vinood B. Patel, Victor R. Preedy
| Biomarkers in Liver Disease [[electronic resource] /] / edited by Vinood B. Patel, Victor R. Preedy |
| Pubbl/distr/stampa | Dordrecht : , : Springer Netherlands : , : Imprint : Springer, , 2020 |
| Descrizione fisica | 1 online resource (800 p. 50 illus.) |
| Disciplina | 614.5999 |
| Collana | Biomarkers in Disease: Methods, Discoveries and Applications |
| Soggetto topico |
Cancer research
Oncology Pharmacology Cancer Research Oncology Pharmacology/Toxicology |
| ISBN | 94-007-7742-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Liver biomarkers and their applications to nutritional interventions in animal studies -- AST-to-platelet ratio index (APRI) as marker in liver disease.-Inflammatory biomarkers in ascites -- Biomarkers for hepatocellular carcinoma in East Asia -- Liver disease and acylcarnitines as mechanistic biomarkers.-Type VI Collagen: Biological Functions and its Neo-epitope as Hepatic Fibrosis Biomarker -- Fibrinogen α-chain as a serum marker of liver disease -- Monocyte chemotactic protein-1 (cytokine, receptors,and gene polymorphisms) in hepatitis -- Biomarkers for Recurrence of Hepatocellular Carcinoma.-Graft-derived cell-free DNA as a biomarker in liver transplantation -- Serum sialic acid as a biomarker in liver disease -- CD133 and EpCAM as Biomarkers in Liver Diseases -- Traditional markers in liver disease -- Biomarkers of extracellular matrix remodeling in liver diseases -- Squamous Cell Carcinoma Antigen- Immunoglobulin M (SCCA-IgM) as biomarker in liver disease: biological aspects and clinical applications -- microRNA-155 and microRNA-196b in hepatitis C virus infection -- Immunological biomarkers in liver transplantation -- Phosphatidylethanol and alcohol use in liver disease patients -- Interaction of sialyltransferases, sialidases and sialic acids in liver diseases and applications to biomarker discovery -- Biomarkers to monitor graft function following liver transplantation -- YKL-40 as a biomarker of liver diseases -- Peripheral venous, portal venous, hepatic venous, arterial and intrahepatic cytokine levels as biomarkers and functional correlations -- Histological Biomarkers of Non-Alcoholic Fatty Liver Disease -- Vascular cell adhesion molecule-1 (vcam-1) expression in liver disease -- Bilirubin as a biomarker in liver disease -- Hydroxyproline as a biomarker in liver disease -- Genetic biomarkers of paracetamol-induced acute liver failure -- PNPLA3 polymorphism and Nonalcoholic Fatty Liver Disease -- Hepascore and it's application to liver disease -- Model for End-Stage Liver Disease (MELD) Score as a Biomarker -- Biomarkers in focus: Alanine Aminotransferase -- PTX3 as a biomarker of liver disease. |
| Record Nr. | UNINA-9910349265903321 |
| Dordrecht : , : Springer Netherlands : , : Imprint : Springer, , 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Branching Process Models of Cancer / / by Richard Durrett
| Branching Process Models of Cancer / / by Richard Durrett |
| Autore | Durrett Richard |
| Edizione | [1st ed. 2015.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2015 |
| Descrizione fisica | 1 online resource (73 p.) |
| Disciplina | 614.5999 |
| Collana | Stochastics in Biological Systems |
| Soggetto topico |
Probabilities
Biomathematics Cancer research Probability Theory and Stochastic Processes Mathematical and Computational Biology Cancer Research |
| ISBN | 3-319-16065-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Multistage Theory of Cancer -- Mathematical Overview -- Branching Process Results -- Time for Z_0 to Reach Size M -- Time Until the First Type 1 -- Mutation Before Detection? -- Accumulation of Neutral Mutations -- Properties of the Gamma Function -- Growth of Z_1(t) -- Movements of Z_1(t) -- Luria-Delbruck Distributions -- Number of Type 1's at Time T_M -- Gwoth of Z_k(t) -- Transitions Between Waves -- Time to the First Type \tau_k, k \ge 2 -- Application: Metastasis -- Application: Ovarian Cancer -- Application: Intratumor Heterogeneity. |
| Record Nr. | UNINA-9910299775603321 |
Durrett Richard
|
||
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cancer control [[electronic resource] ] : knowledge into action / / Cecilia Sepúlveda ... [et al.] ; World Health Organization
| Cancer control [[electronic resource] ] : knowledge into action / / Cecilia Sepúlveda ... [et al.] ; World Health Organization |
| Pubbl/distr/stampa | Geneva, : WHO, c2006 |
| Descrizione fisica | 1 online resource (50 p.) |
| Disciplina | 614.5999 |
| Altri autori (Persone) | Sepúlveda CarvajalCecilia |
| Collana | WHO guide for effective programmes. Module 1, Planning |
| Soggetto topico |
Cancer - Prevention
Tumors - Prevention |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-280-54271-3
9786610542710 1-4294-0230-X 92-4-068016-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Series overview; PLANNING MODULE CONTENTS; KEY MESSAGES; PRE-PLANNING; PLANNING STEP 1: Where are we now?; PLANNING STEP 2: Where do we want to be?; PLANNING STEP 3: How do we get there?; CONCLUSION; REFERENCES; ACKNOWLEDGEMENTS |
| Record Nr. | UNINA-9910450414503321 |
| Geneva, : WHO, c2006 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cancer control [[electronic resource] ] : knowledge into action / / Cecilia Sepúlveda ... [et al.] ; World Health Organization
| Cancer control [[electronic resource] ] : knowledge into action / / Cecilia Sepúlveda ... [et al.] ; World Health Organization |
| Pubbl/distr/stampa | Geneva, : WHO, c2006 |
| Descrizione fisica | 1 online resource (50 p.) |
| Disciplina | 614.5999 |
| Altri autori (Persone) | Sepúlveda CarvajalCecilia |
| Collana | WHO guide for effective programmes. Module 1, Planning |
| Soggetto topico |
Cancer - Prevention
Tumors - Prevention |
| ISBN |
1-280-54271-3
9786610542710 1-4294-0230-X 92-4-068016-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Series overview; PLANNING MODULE CONTENTS; KEY MESSAGES; PRE-PLANNING; PLANNING STEP 1: Where are we now?; PLANNING STEP 2: Where do we want to be?; PLANNING STEP 3: How do we get there?; CONCLUSION; REFERENCES; ACKNOWLEDGEMENTS |
| Record Nr. | UNINA-9910783716003321 |
| Geneva, : WHO, c2006 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cancer control [[electronic resource] ] : knowledge into action / / Cecilia Sepúlveda ... [et al.] ; World Health Organization
| Cancer control [[electronic resource] ] : knowledge into action / / Cecilia Sepúlveda ... [et al.] ; World Health Organization |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Geneva, : WHO, c2006 |
| Descrizione fisica | 1 online resource (50 p.) |
| Disciplina | 614.5999 |
| Altri autori (Persone) | Sepúlveda CarvajalCecilia |
| Collana | WHO guide for effective programmes. Module 1, Planning |
| Soggetto topico |
Cancer - Prevention
Tumors - Prevention |
| ISBN |
1-280-54271-3
9786610542710 1-4294-0230-X 92-4-068016-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Series overview; PLANNING MODULE CONTENTS; KEY MESSAGES; PRE-PLANNING; PLANNING STEP 1: Where are we now?; PLANNING STEP 2: Where do we want to be?; PLANNING STEP 3: How do we get there?; CONCLUSION; REFERENCES; ACKNOWLEDGEMENTS |
| Record Nr. | UNINA-9910823979003321 |
| Geneva, : WHO, c2006 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cancer Drug Discovery [[electronic resource] ] : Science and History / / by Kyu-Won Kim, Jae Kyung Roh, Hee-Jun Wee, Chan Kim
| Cancer Drug Discovery [[electronic resource] ] : Science and History / / by Kyu-Won Kim, Jae Kyung Roh, Hee-Jun Wee, Chan Kim |
| Autore | Kim Kyu-Won |
| Edizione | [1st ed. 2016.] |
| Pubbl/distr/stampa | Dordrecht : , : Springer Netherlands : , : Imprint : Springer, , 2016 |
| Descrizione fisica | 1 online resource (XVII, 276 p. 138 illus., 134 illus. in color.) |
| Disciplina | 614.5999 |
| Soggetto topico |
Cancer research
Pharmacy Medicine—History Cancer Research History of Medicine |
| ISBN | 94-024-0844-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Part Ⅰ. A Scientific Overview on Cancer -- 1. Advancements in Life Sciences and Characteristic Features of Cancer Cells -- 1.1 Characteristics of cancer cells -- 1.2 Characteristic interactions of cancer cells with neighboring cells and the tumor microenvironment -- 2. Advancement of the Science and History of Cancer and Anticancer Drugs -- Part Ⅱ. Cancer Drug Discovery – Types and History -- 3. Chronology of Anticancer Drug Development -- 3.1 A historical background of cancer chemotherapy -- 3.2 Development of the anticancer drug screening systems -- 3.3 Chronology of the anticancer drug development -- 3.4 Clinical application of anticancer drugs -- 4. Alkylating Anticancer Drugs -- 4.1 Classical alkylating drugs -- 4.2 Nonclassical alkylating drugs -- 4.3 Alkylating-like agents: platinum compounds -- 5. Antimetabolic Anticancer Drugs -- 5.1 Folic acid derivatives -- 5.2 Purine analogs -- 5.3 Pyrimidine analogs -- 6. Natural Product Anticancer Drugs -- 6.1 Plant-derived anticancer drugs -- 6.2 Anticancer antibiotics -- 7. Immunotherapeutic Anticancer Drugs and Other Miscellaneous Anticancer Drugs -- 7.1 Immunotherapeutic anticancer drugs -- 7.2 Other miscellaneous anticancer drugs -- 8. Hormonal Anticancer Drugs -- 8.1 Hormonal anti-prostate-cancer drugs -- 8.2 Hormonal anti-breast-cancer drugs -- 8.3 Other hormonal anticancer drugs -- 9. Molecular Targeted Anticancer Drugs -- 9.1 Tretinoin (all-trans retinoic acid, ATRA) -- 9.2 Bcr-Abl Inhibitors -- 9.3 EGFR inhibitors -- 9.4 HER2 inhibitors -- 9.5 Angiogenesis inhibitors -- 9.6 Other kinase inhibitors -- 9.7 mTOR inhibitors -- 9.8 Other targeted anticancer antibody drugs -- 9.9 Epigenetic anticancer drugs -- 9.10 Proteasome inhibitors -- 9.11 Vismodegib: hedgehog pathway blocker -- 10. Complications of Anticancer Drugs and Their Management -- 10.1 Chemotherapy-induced nausea and vomiting (CINV) -- 10.2 Myelotoxicity (bone marrow toxicity) -- 10.3 Chemotherapy-induced diarrhea -- 10.4 Chemotherapy-induced constipation -- 10.5 Chemotherapy-induced urinary toxicity -- 10.6 Chemotherapy-induced pulmonary toxicity -- 10.7 Chemotherapy-induced neurotoxicity -- 10.8 Chemotherapy-induced neurotoxicity -- 10.9 Chemotherapy-induced oral mucositis -- 10.10 Anorexia -- 10.11 Tumor lysis syndrome -- 10.12 Extravasation of anticancer drugs -- 10.13 Chemotherapy-induced skin toxicity -- Part Ⅲ. A Paradigm Shift in Cancer Research -- 11. Advancements in Bioscience and New Cancer Drugs -- 11.1. Development of cancer drugs according to scientific advancements -- 11.2. New anticancer drugs. |
| Record Nr. | UNINA-9910150529103321 |
|
Kim Kyu-Won
|
||
| Dordrecht : , : Springer Netherlands : , : Imprint : Springer, , 2016 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cancer epidemiology / edited by Mukesh Verma
| Cancer epidemiology / edited by Mukesh Verma |
| Pubbl/distr/stampa | New York : Humana Press, 2009 |
| Descrizione fisica | v. ; 27 cm |
| Disciplina | 614.5999 |
| Collana | Methods in molecular biology |
| Soggetto topico | Tumori -- Epidemiologia |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNISA-990003195770203316 |
| New York : Humana Press, 2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
